Endogena Site 002 — Dallas, Texas

Endogena Site 002 is a clinical research site located in Dallas, Texas, United States 75231.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Endogena Site 002 has participated in 1 clinical trials.

Therapeutic areas: Retinitis Pigmentosa, Retinitis Pigmentosa Syndrome.

Sponsors: Endogena Therapeutics, Inc.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Endogena Site 002?

Endogena Site 002 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Endogena Site 002 conducted?

Endogena Site 002 has 1 clinical trials on record. Their work covers Retinitis Pigmentosa, Retinitis Pigmentosa Syndrome.

Is Endogena Site 002 accredited by Crixeo Health?

Endogena Site 002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Endogena Site 002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.